Geocann has launched a portfolio of cannabis formulations that utilize the patent-protected VESIsorb delivery system, designed to dramatically improve the absorption and bioavailability of cannabinoids, including cannabidiol (CBD).
Photo © Shutterstock.com/ElRoi
Geocann (Fort Collins, CO) has launched a portfolio of cannabis formulations that utilize the patent-protected VESIsorb delivery system, designed to dramatically improve the absorption and bioavailability of cannabinoids such as cannabidiol (CBD).
“It is well-documented that cannabinoids are difficult for the body to absorb, and therefore have very slow onset that often takes hours for consumers to receive the desired benefits,” said Jesse Lopez, CEO and founder of Geocann, in a press release. “Geocann has addressed this number-one edible marketplace need by utilizing the VESIsorb delivery system and providing a safe and more effective solution with fast-acting and predictable onset.”
Geocann states that it has successfully manufactured formulations in a range of delivery formats, including chocolate, gummies, fruit bites, protein bars, stick-pack powders, beverages, as well as soft gels. The company is partnering with strategic brand leaders in key channels of distribution to deliver its patent-protected products to the industrial hemp, medical marijuana, and adult-use marijuana markets in the U.S. and internationally.
“Formulations utilizing VESIsorb ensure that health conscious consumers receive the maximum benefits from key cannabinoids, like cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabigerol (CBG),” said Marc Weder, Geocann’s chief scientific officer, in a press release. “These new food and beverage formulations are a showcase of Geocann’s commitment to consumer safety and product efficacy by transferring a rigorous product development protocol to the large-scale commercial production of the most sought-after cannabis products.”
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.